drug

/Tag:drug
­

Biobide signs new contracts worth of USD 1.39 million

Biobide -Bionaturis group- an international reference CRO on zebrafish, reports that it has signed new relevant contracts with three leading companies in the agrochemical and biomedicine sectors, for a cumulative amount worth of USD 1.39 million. Under the terms of these new contracts, Biobide will use its zebrafish platform for the optimization of the drug discovery process of the customers. Using this platform, Biobide´s customers can filter and early-detect the safety and efficacy profile of its leads, meaning a significant saving of time and costs.

These new relevant contracts are just another example of Biobide’s leadership position in the growing zebrafish sector. Customers like Roche, Servier, Sanofi, or NIH-NIEH endorse Biobide as an international reference CRO in zebrafish.

For the official disclosing Click here (Only in Spanish)
 

September 28th, 2017|Blog english|Comments Off on Biobide signs new contracts worth of USD 1.39 million

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

CERRAR